Moderna’s Personalized Cancer Vaccine Scores Late-Stage Win Cheddar Aug 19, 2026 Aug 19, 2026 Updated Aug 19, 2026 0 Cam Buffington | Iowa Football | Sept. 5 The AI attack that sparked current concerns about future threats Week 1 Fantasy Football BUSTS Deshaun Lee | Iowa Football | Sept. 8 Braeden Jackson | Iowa Football | Sept. 19 RAW: RPT: US STRIKE MAY HAVE BEEN WAR CRIME Zach Lutmer | Iowa Football | Sept. 15 Jenna Meitzler | Iowa Volleyball | Sept. 16 NFL Season Predictions 2026: Super Bowl Matchup, Playoff Bracket, And More Prefer us on Google Learn More Moderna and Merck say their personalized mRNA cancer vaccine significantly reduced the risk of melanoma returning or spreading. As featured on Moderna, Merck breakthrough could usher in cancer vaccines The companies said their vaccine helped prevent the return and spread of melanoma in a trial that involved more than 1,000 patients. Latest video US LBM Coaches Poll: Ole Miss climbs after emotional win over LSU Xavier Williams | Iowa Football | Sept. 19 Kirk Ferentz | Iowa Football | Sept. 19 Hank Brown | Iowa Football | Sept. 19 Addison Ostrenga | Iowa Football | Sept. 19 Jacob Wallace | Iowa Football | Sept. 19 Nathan McNeil | Iowa Football | Sept. 19 Braeden Jackson | Iowa Football | Sept. 19 Facebook Twitter Bluesky WhatsApp SMS Email Print Copy article link Save 0 Comments
Moderna, Merck breakthrough could usher in cancer vaccines The companies said their vaccine helped prevent the return and spread of melanoma in a trial that involved more than 1,000 patients.
